LISTED natural medicines and medicinal cannabis company Bod Australia has signed a distribution agreement with its second large pharmacy wholesaler, Symbion.
Under the agreement, Symbion will stock Bod's range of natural medicines, as well as its pregnancy supplement, Mamacare.
Bod said Symbion gives it access to more than 3,500 pharmacy customers across the nation, complementing its existing agreement with API (PD 05 Apr).
The distribution deals allow Bod to "better utilise working capital by leveraging centralised delivery points and more stringent payment periods," the company said.
Bod Australia ceo Jo Patterson said: "Not only does this agreement provide ongoing validation of our product range, but coupled with the recent progression of our relationship with API, it provides the Company with access to over two thirds of the Australian pharmaceutical market.
"We look forward to working with Symbion to promote our products through their network of over 3,500 pharmacies and specialty retailers to ensure Bod's products achieve greater market penetration and drive revenue growth."
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jun 18
